Comparative Pharmacology
Head-to-head clinical analysis: ACLOVATE versus HC 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACLOVATE versus HC 1.
ACLOVATE vs HC #1
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aclovate (alclometasone dipropionate) is a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Its mechanism involves binding to glucocorticoid receptors, modulating gene expression to inhibit phospholipase A2, reducing arachidonic acid release, and decreasing prostaglandin and leukotriene synthesis.
Unknown
Apply a thin film to affected skin areas twice daily. Not for ophthalmic, oral, or intravaginal use.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
None Documented
None Documented
Terminal elimination half-life: approximately 6-8 hours after topical application; systemic absorption is minimal under normal use.
2–4 hours (terminal); prolonged in renal impairment.
Renal (primarily as metabolites, <5% unchanged), biliary/fecal (minor).
Renal: 90% as unchanged drug; fecal: 10%.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid